LENZ Therapeutics, Inc. Common Stock
Symbol: LENZ (NASDAQ)
48.99
▲ (5.16%) 2.405
Company Description:
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
Key Stats
- Today's Open: $47.25
- Today's High: $49.175
- Today's Low: $46.865
- Today's Volume: 593.38K
- Yesterday Close: $46.58
- Yesterday High: $47.49
- Yesterday Low: $44.935
- Yesterday Volume: 867.40K
- Last Min Volume: 2
- Last Min High: $48.985
- Last Min Low: $48.985
- Last Min VWAP: $48.985
Company Profile
- Name: LENZ Therapeutics, Inc. Common Stock
- Website: https://www.lenz-tx.com
- Listed Date: 2024-03-22
- Location: SOLANA BEACH, CA
- Market Status: Active
- CIK Number: 0001815776
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $1.33B
- Round Lot: 100
- Outstanding Shares: 28.52M
- Asset Type: CS
RECENT FILINGS FOR LENZ
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-30 | 8-K | View |
| 2025-09-22 | 4 | View |
| 2025-09-22 | SCHEDULE 13D/A | View |
| 2025-08-26 | 4 | View |
| 2025-08-20 | SCHEDULE 13D/A | View |
| 2025-08-19 | 4 | View |
| 2025-07-31 | 8-K | View |
| 2025-07-30 | 10-Q | View |
| 2025-07-30 | 8-K | View |
| 2025-07-14 | SCHEDULE 13D/A | View |
| 2025-07-14 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-06-24 | SCHEDULE 13D/A | View |
| 2025-06-20 | 4 | View |
| 2025-06-12 | SCHEDULE 13D/A | View |
| 2025-06-12 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
Latest News on LENZ